RT Journal Article
SR Electronic
T1 Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.02.21252763
DO 10.1101/2021.03.02.21252763
A1 Sushma Dahal
A1 Juan M. Banda
A1 Ana I. Bento
A1 Kenji Mizumoto
A1 Gerardo Chowell
YR 2021
UL http://medrxiv.org/content/early/2021/04/19/2021.03.02.21252763.abstract
AB Background Low testing rates and delays in reporting hinder the estimation of the mortality burden associated with the COVID-19 pandemic. During a public health emergency, estimating all cause excess deaths above an expected level of death can provide a more reliable picture of the mortality burden. Here, we aim to estimate the absolute and relative mortality impact of COVID-19 pandemic in Mexico.Methods We obtained weekly mortality time series due to all causes for Mexico, and by gender, and geographic region from 2015 to 2020. We also compiled surveillance data on COVID-19 cases and deaths to assess the timing and intensity of the pandemic and assembled weekly series of the proportion of tweets about ‘death’ from Mexico to assess the correlation between people’s media interaction about ‘death’ and the rise in pandemic deaths. We estimated all-cause excess mortality rates and mortality rate ratio increase over baseline by fitting Serfling regression models and forecasted the total excess deaths for Mexico for the first four weeks of 2021 using the generalized logistic growth model.Results We estimated the all-cause excess mortality rate associated with the COVID-19 pandemic in Mexico in 2020 at 26.10 per 10,000 population, which corresponds to 333,538 excess deaths. Males had about 2-fold higher excess mortality rate (33.99) compared to females (18.53). Mexico City reported the highest excess death rate (63.54) and RR (2.09) compared to rest of the country (excess rate=23.25, RR=1.62). While COVID-19 deaths accounted for only 38.64% of total excess deaths in Mexico, our forecast estimate that Mexico has accumulated a total of ∼61610 [95% PI: 60003, 63216] excess deaths in the first four weeks of 2021. Proportion of tweets was significantly correlated with the excess mortality (ρ=0.508 [95% CI: 0.245, 0.701], p-value=0.0004).Conclusion The COVID-19 pandemic has heavily affected Mexico. The lab-confirmed COVID-19 deaths accounted for only 38.64% of total all cause excess deaths (333,538) in Mexico in 2020. This reflects either the effect of low testing rates in Mexico, or the surge in number of deaths due to other causes during the pandemic. A model-based forecast indicates that an average of 61,610 excess deaths have occurred in January 2021.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGC is partially supported by NSF grant No.'s 2026797, 2034003, and NIH R01 GM 130900. KM is supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI [grant 20H03940] and Japan Science and Technology Agency (JST) J-RAPID [grant JPMJJR2002].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for the study is publicly available.